Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Serotonin Syndrome × Endocrine × Clear all

Phase

Phase 2 7 Phase 3 4 Phase NA 2 Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Pituitary Neoplasms 14 Neuroendocrine Tumors 13 Multiple Endocrine Neoplasia Type 1 9 Inflammation 4 Acromegaly 4 Sexual Dysfunction, Physiological 3 Pheochromocytoma 3 Obesity 3 Neoplasms 3 Gastro-enteropancreatic neuroendocrine tumor 3 Thyroid Cancer, Papillary 2 Prostatic Neoplasms 2 Pituitary Diseases 2 Paraganglioma 2 Carcinoid Tumor 2 Adrenal Gland Neoplasms 2 Zollinger-Ellison Syndrome 1 Vitamin D Deficiency 1 Serotonin Syndrome 1 Pituitary ACTH Hypersecretion 1 Pancreatic Neuroendocrine Tumors 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Pain 1 Neuroendocrine Tumour With Carcinoid Symptoms 1 Multiple Endocrine Neoplasia 1 Meningioma 1 Melanoma 1 Medulloblastoma 1 Hypothyroidism 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04140409 2019-10-25

SCIROCCO

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 4 Terminated

Neuroendocrine Tumors, Serotonin Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡